Image for Voyager Clinical Trial


A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).

Location Description

The mission of the Motol Teaching Hospital is to treat patients on the basis of current medical science knowledge and to provide their clients with comprehensive and high-quality highly specialized care for all phases of human life. The mission summarizes the motto: we serve generations.

Praha, Czechia Clinical Trial Location

Fackultni Nemocnice v Motole
V Úvalu 84,
150 06 Praha 5, Czechia